OSRH Q4 2023 Earnings — OSR Holdings, Inc. Revenue & Financial Results | Market Cap Arena

OSRHOSR Holdings, Inc.

$13M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$862,000

Net Income

-$86,172

EPS (Diluted)

$-0.01

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$279,493

Free Cash Flow

-$279,493

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$37M

Total Liabilities

$4M

Stockholders' Equity

$33M

Cash & Equivalents

$15,419

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$862,000	-$14,252	-5948.3%
Net Income	-$86,172	-$14,252	-504.6%